Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?

Stem Cells
Catherine TangAparajita Khatri

Abstract

Ineffective treatment and poor patient management continue to plague the arena of clinical oncology. The crucial issues include inadequate treatment efficacy due to ineffective targeting of cancer deposits, systemic toxicities, suboptimal cancer detection and disease monitoring. This has led to the quest for clinically relevant, innovative multifaceted solutions such as development of targeted and traceable therapies. Mesenchymal stem cells (MSCs) have the intrinsic ability to "home" to growing tumors and are hypoimmunogenic. Therefore, these can be used as (a) "Trojan Horses" to deliver gene therapy directly into the tumors and (b) carriers of nanoparticles to allow cell tracking and simultaneous cancer detection. The camouflage of MSC carriers can potentially tackle the issues of safety, vector, and/or transgene immunogenicity as well as nanoparticle clearance and toxicity. The versatility of the nanotechnology platform could allow cellular tracking using single or multimodal imaging modalities. Toward that end, noninvasive magnetic resonance imaging (MRI) is fast becoming a clinical favorite, though there is scope for improvement in its accuracy and sensitivity. In that, use of superparamagnetic iron-oxide nanoparticles (SPI...Continue Reading

References

Jan 1, 1976·International Review of Cytology·A J Friedenstein
Sep 1, 1991·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·A I Caplan
May 1, 1983·Journal of Clinical Pathology·K C GatterD Y Mason
Apr 21, 1998·Bioconjugate Chemistry·M M HüberT J Meade
Apr 2, 1999·Science·M F PittengerD R Marshak
Aug 24, 1999·Journal of Cellular Physiology·P A Conget, J J Minguell
Sep 22, 1999·Gene Therapy·N ChirmuleJ Wilson
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·J W BulteJ A Frank
Sep 9, 2000·Biological Psychiatry·D C MacLarenS S Gambhir
Oct 19, 2000·Current Topics in Microbiology and Immunology·M F PittengerK R McIntosh
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·K S AboodyE Y Snyder
Jun 16, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·K LeeJ D Mosca
May 16, 2002·Bioconjugate Chemistry·Lee JosephsonRalph Weissleder
Jun 22, 2002·Nature·Yuehua JiangCatherine M Verfaillie
Aug 22, 2002·Academic Radiology·Mukesh G HarisinghaniRalph Weissleder
Nov 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Mathias HoehnChristian Bührle
Apr 22, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Paula Foster-GareauBrian K Rutt
May 3, 2003·Nature Reviews. Genetics·Clare E ThomasMark A Kay
May 7, 2003·Circulation·Dara L KraitchmanJeff W M Bulte
May 28, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·E T AhrensP A Morel
Jun 13, 2003·Radiology·Heiko AlfkeKlaus Jochen Klose
Jun 20, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Jeff W M BulteJoseph A Frank
Jun 24, 2003·Biological Chemistry·Christian PlankJoseph Rosenecker
Jul 24, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·H KalishJ A Frank
Aug 13, 2003·Circulation·Jonathan M HillRobert J Lederman
Aug 14, 2003·Ecotoxicology and Environmental Safety·Eugen S GurzauAnca Elena Gurzau
Aug 29, 2003·Biochemical and Biophysical Research Communications·Genichiro IshiiAtsushi Ochiai
Sep 4, 2003·The Cancer Journal·Stephen YipEvan Y Snyder
Oct 11, 2003·Experimental Hematology·Katarina Le BlancOlle Ringdén

❮ Previous
Next ❯

Citations

Mar 9, 2012·Journal of the American Chemical Society·Johanna M NiersBakhos A Tannous
Apr 24, 2012·Stem Cell Research & Therapy·Ian WimpennyAlicia J El Haj
Apr 1, 2011·Therapeutic Delivery·Joel C SunshineJordan J Green
Dec 25, 2012·Regenerative Medicine·Kevin Gregory-EvansChristopher Laver
Mar 7, 2012·Expert Review of Clinical Pharmacology·Mamta WankhedeCostas G Hadjipanayis
Feb 23, 2011·Expert Opinion on Drug Delivery·Nupura S BhiseJordan J Green
May 9, 2015·Current Opinion in Biotechnology·Scott A WalperIgor L Medintz
Oct 31, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Min LiEn-Tang Kang
Jul 4, 2012·Neurosurgery Clinics of North America·Edjah K NduomCostas G Hadjipanayis
Feb 22, 2012·Clinics in Laboratory Medicine·Kewal K Jain
Nov 15, 2011·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·V Krutovskikh, C Partensky
Dec 30, 2014·Advanced Drug Delivery Reviews·Qun WangRobert Langer
Jan 1, 2013·IEEE Transactions on Magnetics·Abu Emran BasharKevin Gregory-Evans
Jul 19, 2012·Biomedical Optics Express·Jean R StarkeyAleksander Rebane
Apr 2, 2013·Gene·Guillaume ColletClaudine Kieda
Dec 3, 2014·Cancer Letters·M C F SimõesA A C C Pais
Jan 27, 2015·Nanoscale·Haisheng PengQun Wang
Jun 22, 2013·Chemical Society Reviews·Juan GalloEric O Aboagye
Mar 19, 2014·Integrative Biology : Quantitative Biosciences From Nano to Macro·Jaeha ShinMisun Cha
Jun 9, 2019·The Journal of Pharmacology and Experimental Therapeutics·Shen ChengSwayam Prabha
Jan 7, 2017·Stem Cells International·Janaina PauliniÉrika B Rangel
May 6, 2019·Expert Review of Anticancer Therapy·Carla SouzaAntonio Claudio Tedesco
Jun 4, 2021·Bioconjugate Chemistry·Marco BassettoOlivier Zelphati

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
genetic modification
xenograft
transfection
ELISA

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.